Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/30/2007 | WO2006078659A8 Stable prostaglandin-containing compositions |
08/30/2007 | WO2005037856A3 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
08/30/2007 | WO2004050536A3 Fluid delivery device having a thermal equilibrating element |
08/30/2007 | WO2000003682A3 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal |
08/30/2007 | WO2000001393A8 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
08/30/2007 | US20070203476 Osmotic Delivery System Having Space Efficient Piston |
08/30/2007 | US20070203462 Device and method for exothermic treatment of eyelid diseases |
08/30/2007 | US20070203357 Freeze-dried product of n-[o-(p-pivaloyloxy benzenesulfonylamino) benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof |
08/30/2007 | US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
08/30/2007 | US20070203195 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
08/30/2007 | US20070203166 Administering non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect and anticancer agent |
08/30/2007 | US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
08/30/2007 | US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
08/30/2007 | US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
08/30/2007 | US20070203069 Grf-containing lyophilized pharmaceutical compositions |
08/30/2007 | US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
08/30/2007 | US20070202598 New transfection reagents |
08/30/2007 | US20070202212 Chewing gum containing controlled release acyclic carboxamides |
08/30/2007 | US20070202201 Pharmaceutics of treaditiional chinese medicine of treating aids and preparation method thereof |
08/30/2007 | US20070202187 Dosage forms |
08/30/2007 | US20070202186 Apparatus and formulations for suprachoroidal drug delivery |
08/30/2007 | US20070202185 Microencapsulated Delivery Vehicles Having Fugitive Layers |
08/30/2007 | US20070202184 Liquid Compositions Including Microencapsulated Delivery Vehicles |
08/30/2007 | US20070202183 Composition and method for preparing alginate nanocapsules |
08/30/2007 | US20070202182 Preparing solid formulation of nanoparticles of pharmaceutical ingredient, including at least micron-sized particles |
08/30/2007 | US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof |
08/30/2007 | US20070202180 Nanoparticulate carverdilol formulations |
08/30/2007 | US20070202179 Low Dose Pharmaceutical Products |
08/30/2007 | US20070202178 Drug delivery matrices to enhance wound healing |
08/30/2007 | US20070202177 Antimicrobial Compositions and Methods for Locking Catheters |
08/30/2007 | US20070202176 Bacteria Support Material |
08/30/2007 | US20070202175 Compressed tablet formulation containing active ingredient 4'-azidocytidine-2', 3', 5'-tri-isobutyrate hydrochloride and ethylene glycol-propylene glycol block copolymer; gel inhibition during formulation; enhanced gastrointestinal dissolution and absorption; hepatitis C virus |
08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |
08/30/2007 | US20070202173 Biodegradable, non-toxic biological adhesive for use in abdominal surgery |
08/30/2007 | US20070202172 Metoprolol succinate E.R. tablets and methods for their preparation |
08/30/2007 | US20070202171 Method Of Producing A Pharmaceutical Composition |
08/30/2007 | US20070202170 Dual-release compositions of a cyclooxygenase-2 inhibitor |
08/30/2007 | US20070202169 Lansoprazole orally disintegrating tablets |
08/30/2007 | US20070202168 Composition comprises sustained-release fine particles and manufacturing method thereof |
08/30/2007 | US20070202167 Hyoscyamine dosage form |
08/30/2007 | US20070202166 Method for increasing the rate and consistency of bioavailability of supplemental dietary ingredients |
08/30/2007 | US20070202165 Method for a supplemental dietary composition having a multi-phase dissolution profile |
08/30/2007 | US20070202164 Andrographis Extract Formulations |
08/30/2007 | US20070202163 Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
08/30/2007 | US20070202162 Extended release pharmaceutical compositions |
08/30/2007 | US20070202161 Pharmaceutical Formulations |
08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
08/30/2007 | US20070202159 Pharmaceutical composition comprising stabilized statin particles |
08/30/2007 | US20070202158 Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation |
08/30/2007 | US20070202157 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome |
08/30/2007 | US20070202156 Adhesive preparation comprising sufentanil and methods of using same |
08/30/2007 | US20070202155 Low dose no donor-containing transdermal patch |
08/30/2007 | US20070202152 Method For Encapsulation Of Orally Ingested Materials To Alter The Site Of Digestion, Site Of Action, Or Stability |
08/30/2007 | US20070202143 Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints |
08/30/2007 | US20070202142 Biomaterial, injectable implant comprising it, its method of preparation and its uses |
08/30/2007 | US20070202139 Use of microcapsules for making paints and lacquers |
08/30/2007 | US20070202137 Device For Sensing Of Motile Living Organisms And Uses Thereof |
08/30/2007 | US20070202136 Method for reducing the contamination properties of a surface by micro-organisms |
08/30/2007 | US20070202080 Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin |
08/30/2007 | US20070202067 Stable oil-in-water and water/oil/water multiple emulsions and hair treating compositions comprising them |
08/30/2007 | US20070202058 Compositions for treating gastric reflux |
08/30/2007 | US20070202057 Disintegrable oral films |
08/30/2007 | US20070202056 Oral composition for improving mouth environment |
08/30/2007 | US20070202055 Pharmaceutical Formulations |
08/30/2007 | US20070202054 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid |
08/30/2007 | US20070202053 Pharmaceutical Formulations For Dry Powder Inhalers Comprising A Low-Dosage Strength Active Ingredient |
08/30/2007 | US20070202052 Method for increasing the expression of pulmonary surfactant protein-B |
08/30/2007 | US20070202051 Aerosols for sinunasal drug delivery |
08/30/2007 | US20070202050 Pharmaceutical Formulations |
08/30/2007 | US20070202049 Oral dosage form comprising an antimisuse system |
08/30/2007 | US20070202040 Supplying radionuclide to blood clot; ultrasonic imaging; diagnosis, therapy |
08/30/2007 | US20070202024 Phase transformation in molecular solids |
08/30/2007 | US20070201992 Infusion Pump System, an Infusion Pump Unit and an Infusion Pump |
08/30/2007 | US20070201024 Method and apparatus for semi-permeable membrane detection on osmotic tablets incorating near-infrared spectroscopy |
08/30/2007 | US20070199898 Dialysate of peritoneal dialysis and its preparation method |
08/30/2007 | DE102006017679A1 Aerosol und Verwendungen desselben Aerosol and uses thereof |
08/30/2007 | DE102006007830A1 Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure A storage-stable oral dosage form of amoxicillin and clavulanic acid |
08/30/2007 | DE102006007482A1 Vorrichtung zur Herstellung einer mit Substanzen beschickbaren rohrförmigen Umhüllung Apparatus for manufacturing a tubular envelope be charged with substances |
08/30/2007 | DE10045374B4 Verfahren zur Herstellung von Mikroteilchen mit verzögerter Freisetzung Process for the preparation of sustained release microparticles |
08/30/2007 | CA2661700A1 Nanoparticles for immunotherapy |
08/30/2007 | CA2643566A1 Medicated patch |
08/30/2007 | CA2643464A1 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
08/30/2007 | CA2643274A1 Oil-in-water emulsion composition containing licorice-derived polyphenol |
08/30/2007 | CA2643054A1 Granules, tablets and method of producing the same |
08/30/2007 | CA2642952A1 Pharmaceutical composition comprising oseltamivir phosphate |
08/30/2007 | CA2642487A1 Novel application of topical anesthetics for modulation of neurogenic tremor |
08/30/2007 | CA2642340A1 Metoprolol succinate e.r. tablets and methods for their preparation |
08/30/2007 | CA2642167A1 Fluoroquinolone compositions |
08/30/2007 | CA2642048A1 Phenylephrine containing liquid formulations |
08/30/2007 | CA2640331A1 Stabilized pharmaceutical composition |
08/30/2007 | CA2630112A1 Antimicrobial cellulosic sheet |
08/29/2007 | EP1826198A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid |
08/29/2007 | EP1825866A1 Solid preparation |
08/29/2007 | EP1825863A1 Recombinant porcine adenovirus vector |
08/29/2007 | EP1825861A2 Anti-inflammatory extract and agent and method for the production thereof |
08/29/2007 | EP1825855A1 Product containing prostaglandin having fluorine atom in molecule |
08/29/2007 | EP1825849A1 Transdermal therapeutic system comprising fentanyl |
08/29/2007 | EP1825848A2 Stable pharmaceutical compositions comprising an HMG-CoA reductase inhibitor |
08/29/2007 | EP1825847A2 Fluvastatin sodium pharmaceutical compositions |
08/29/2007 | EP1825846A2 Implantable device formed from solution processing |